MX9801111A - Tableta moldeada masticable que contiene sustancias medicinalmente activas. - Google Patents
Tableta moldeada masticable que contiene sustancias medicinalmente activas.Info
- Publication number
- MX9801111A MX9801111A MX9801111A MX9801111A MX9801111A MX 9801111 A MX9801111 A MX 9801111A MX 9801111 A MX9801111 A MX 9801111A MX 9801111 A MX9801111 A MX 9801111A MX 9801111 A MX9801111 A MX 9801111A
- Authority
- MX
- Mexico
- Prior art keywords
- weight
- medicinally active
- percent
- chewable
- active substances
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Preparation (AREA)
Abstract
Se proporciona una composicion para hacer una tableta medicinal masticable. que comprende en proporciones de la composicion en total, misma que además comprenderá el componente medicinalmente activo, como primer componente esencial el triglicérido cáprico en una cantidad de 30 a 95% en peso, aproximadamente, y como segundo componente esencial, el ingrediente medicinalmente activo en una cantidad hasta de 60% en peso. Cuando el ingrediente medicinalmente activo es menos de un 30% en peso, la composicion comprende adicionalmente como tercer componente esencial, un miembro del grupo compuesto por monoestearato de glicerilo, una mezcla de monoestearato de glicerilo y monopalmitato de glicerilo así como una mezcla que consta al menos un 40 a 50% en peso de monestearato de glicerilo y diestearato de glicerilo en una cantidad hasta de 10% en peso. Igualmente se dan a conocer métodos para elaborar estas composiciones.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/795,472 US5753255A (en) | 1997-02-11 | 1997-02-11 | Chewable molded tablet containing medicinally active substances |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9801111A true MX9801111A (es) | 1998-11-29 |
Family
ID=25165600
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9801111A MX9801111A (es) | 1997-02-11 | 1998-02-10 | Tableta moldeada masticable que contiene sustancias medicinalmente activas. |
Country Status (3)
Country | Link |
---|---|
US (1) | US5753255A (es) |
CA (1) | CA2228704A1 (es) |
MX (1) | MX9801111A (es) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5891476A (en) * | 1997-12-22 | 1999-04-06 | Reo; Joe P. | Tastemasked pharmaceutical system |
US6060078A (en) * | 1998-09-28 | 2000-05-09 | Sae Han Pharm Co., Ltd. | Chewable tablet and process for preparation thereof |
US6296868B1 (en) | 1998-11-19 | 2001-10-02 | Advanced Technology Pharmaceuticals Corporation | Chewable tablets containing mannitol and aspartame |
US6531114B1 (en) | 1999-04-06 | 2003-03-11 | Wm. Wrigley Jr. Company | Sildenafil citrate chewing gum formulations and methods of using the same |
US6627234B1 (en) | 1998-12-15 | 2003-09-30 | Wm. Wrigley Jr. Company | Method of producing active agent coated chewing gum products |
US6586023B1 (en) | 1998-12-15 | 2003-07-01 | Wm. Wrigley Jr. Company | Process for controlling release of active agents from a chewing gum coating and product thereof |
US7163705B2 (en) * | 1998-12-15 | 2007-01-16 | Wm. Wrigley Jr. Company | Coated chewing gum product and method of making |
US7014864B1 (en) * | 1998-12-18 | 2006-03-21 | Abbott Laboratories | Formulations comprising lipid-regulating agents |
US6322806B1 (en) | 1999-04-06 | 2001-11-27 | Wm. Wrigley Jr. Company | Over-coated chewing gum formulations including tableted center |
US6773716B2 (en) | 1999-04-06 | 2004-08-10 | Wm. Wrigley Jr. Company | Over-coated chewing gum formulations |
US7935362B2 (en) * | 1999-04-06 | 2011-05-03 | Wm. Wrigley Jr. Company | Over-coated product including consumable center and medicament |
US20020159956A1 (en) * | 1999-04-06 | 2002-10-31 | Ream Ronald L. | Over-coated chewing gum formulations |
US6355265B1 (en) | 1999-04-06 | 2002-03-12 | Wm. Wrigley Jr. Company | Over-coated chewing gum formulations |
US6426090B1 (en) * | 1999-04-06 | 2002-07-30 | Wm. Wrigley Jr. Company | Over-coated product including tableted center and medicament |
US6569472B1 (en) | 2000-09-01 | 2003-05-27 | Wm. Wrigley Jr. Company | Coated chewing gum products containing antacid and method of making |
US6541048B2 (en) | 1999-09-02 | 2003-04-01 | Wm. Wrigley Jr. Company | Coated chewing gum products containing an acid blocker and process of preparing |
US6645535B2 (en) | 1999-09-02 | 2003-11-11 | Wm. Wrigley Jr. Company | Method of making coated chewing gum products containing various antacids |
US6663849B1 (en) | 2000-09-01 | 2003-12-16 | Wm. Wrigley Jr. Company | Antacid chewing gum products coated with high viscosity materials |
AU3885201A (en) | 1999-09-20 | 2001-04-24 | Mastercare | Diet and weight control gum and sucker |
US9253991B2 (en) | 1999-09-20 | 2016-02-09 | Jack Barreca | Chewing gum with B vitamins |
US9387168B2 (en) | 1999-09-20 | 2016-07-12 | Jack Barreca | Chewing gum with tomatidine |
US7115288B2 (en) * | 2000-06-09 | 2006-10-03 | Wm. Wrigley Jr. Company | Method for making coated chewing gum products with a coating including an aldehyde flavor and a dipeptide sweetener |
US6572900B1 (en) | 2000-06-09 | 2003-06-03 | Wm. Wrigley, Jr. Company | Method for making coated chewing gum products including a high-intensity sweetener |
WO2002002081A1 (en) * | 2000-07-05 | 2002-01-10 | Capricorn Pharma, Inc. | Rapid-melt semi-solid compositions, methods of making same and methods of using same |
US6375982B1 (en) | 2000-07-05 | 2002-04-23 | Capricorn Pharma, Inc. | Rapid-melt semi-solid compositions, methods of making same and method of using same |
US6444241B1 (en) | 2000-08-30 | 2002-09-03 | Wm. Wrigley Jr. Company | Caffeine coated chewing gum product and process of making |
US6579545B2 (en) | 2000-12-22 | 2003-06-17 | Wm. Wrigley Jr. Company | Coated chewing gum products containing an antigas agent |
US20040052852A1 (en) * | 2001-09-25 | 2004-03-18 | Michael Farber | Carbohydrate-based delivery system for creatine and other bioactive ingredients |
US7067150B2 (en) * | 2002-04-16 | 2006-06-27 | Scepter Holdings, Inc. | Delivery systems for functional ingredients |
JP4995407B2 (ja) | 2002-04-25 | 2012-08-08 | バナー ファーマキャップス, インコーポレーテッド | 咀嚼可能なソフトカプセル |
US20030235613A1 (en) * | 2002-06-19 | 2003-12-25 | Cts Chemical Industries Ltd. | Popping oral administration form |
EP2314171B1 (en) | 2002-08-13 | 2019-11-13 | Intervet International BV | Compositions and process for delivering an additive |
US20080160086A1 (en) * | 2004-02-19 | 2008-07-03 | Scepter Holdings, Inc. | Delivery Systems For Calcium |
AU2005232685A1 (en) * | 2004-04-07 | 2005-10-27 | Intervet International B.V. | Efficacious composition of a benzimidazole, an avermectin and praziquantel and related methods of use |
US7955632B2 (en) | 2005-12-07 | 2011-06-07 | Bayer B.V. | Process for manufacturing chewable dosage forms for drug delivery and products thereof |
US20070128251A1 (en) * | 2005-12-07 | 2007-06-07 | Piedmont Pharmaceuticals, Inc. | Process for manufacturing chewable dosage forms for drug delivery and products thereof |
WO2013068371A1 (en) | 2011-11-08 | 2013-05-16 | Intervet International B.V. | Soft chewable dosage form compositions of cannabinoid receptor type 1 (cb-1) antagonists |
BR122020022192B1 (pt) | 2012-02-06 | 2021-12-07 | Merial, Inc | Composições orais veterinárias parasíticas compreendendo ingredientes ativos de ação sistêmica, métodos e uso das mesmas |
US20150057321A1 (en) | 2012-04-04 | 2015-02-26 | Intervet Inc. | Soft chewable pharmaceutical products |
US20180027856A1 (en) * | 2015-02-26 | 2018-02-01 | The Nisshin Oillio Group, Ltd. | Cool-feeling imparted food product |
CA3201608A1 (en) | 2020-12-18 | 2022-06-23 | Boehringer Ingelheim Animal Health USA Inc. | Boron containing pyrazole compounds, compositions comprising them, methods and uses thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS50157517A (es) * | 1974-06-14 | 1975-12-19 | ||
JPH0612632Y2 (ja) * | 1989-05-15 | 1994-03-30 | 矢崎総業株式会社 | スライドカバー付コネクタ |
-
1997
- 1997-02-11 US US08/795,472 patent/US5753255A/en not_active Expired - Fee Related
-
1998
- 1998-02-04 CA CA002228704A patent/CA2228704A1/en not_active Abandoned
- 1998-02-10 MX MX9801111A patent/MX9801111A/es unknown
Also Published As
Publication number | Publication date |
---|---|
US5753255A (en) | 1998-05-19 |
CA2228704A1 (en) | 1998-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9801111A (es) | Tableta moldeada masticable que contiene sustancias medicinalmente activas. | |
CA2209167A1 (en) | Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof | |
GEP20043161B (en) | Piperidines as CCR5 Modulators, Pharmaceutical Compositions Containing the Same and Their Use for Treatment and Prevention of Diseases Caused by CCR5 Modulators | |
CA2179682A1 (en) | Pharmaceutical, orally applicable composition | |
AU764280C (en) | Process for the preparation of pellets with a content of up to 90 wt. per cent of a pharmaceutical active ingredient | |
IE881916L (en) | Press-coated dihydropyridine tablets | |
ES2002140A6 (es) | Procedimiento para producir preparados de derivados de acido arilpropionico resorbibles por via transdermal y acuosos | |
WO1997012583A3 (en) | Stable compositions containing n-propargyl-1-aminoindan | |
EG26287A (en) | Fixed solid composition containing pregabalin, glycol or glycerol as moisturizer | |
CA2294337A1 (en) | Preparation of pharmaceutical compositions | |
MY126625A (en) | Compositions containing diphosphonic acids | |
PT85591A (en) | Process for the preparation of multiple unit dosage pharmaceutical compositions comprising as a pharmaceutilly active compound l-dopa | |
CA2065285A1 (en) | Antimalarial compositions | |
CA2195419A1 (en) | Immunological activity of rhamnolipids | |
CA2384859A1 (en) | High lipid diet | |
TW345496B (en) | Skin care composition containing retinol | |
IE800406L (en) | Pharmaceutical composition | |
IE781032L (en) | Pharmaceutical compositions | |
CA2085258A1 (en) | Method for growth promotion of animals and powder compositions containing killed microbial cells of bacteria belonging to genus clostridium | |
GEP19991872B (en) | Novel Taxoids, Preparations Thereof, and Pharmaceutical Compositions Containing Same | |
CA2016221A1 (en) | Compositions | |
AU2420001A (en) | Methods and compositions for the treatment of pain | |
WO1991018606A3 (en) | Orally active nonaddicting analgesics | |
AU3271795A (en) | Synergistic pharmaceutical compositions containing triamcinolone acetonide and halcinonide | |
UA42704C2 (uk) | (+)-складний етиловий ефір транс-2-диметиламіно-1-феніл-3-циклогексен-транс-1-карбонової кислоти і тверда фармацевтична композиція, що виявляє знеболювальну активність |